These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats. Criswell HE; Johnson KB; Mueller RA; Breese GR J Pharmacol Exp Ther; 1993 May; 265(2):1001-10. PubMed ID: 8098756 [TBL] [Abstract][Full Text] [Related]
3. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion. Miller FE; Heffner TG; Kotake C; Seiden LS Brain Res; 1981 Dec; 229(1):123-32. PubMed ID: 6796194 [TBL] [Abstract][Full Text] [Related]
4. Impaired acquisition and operant responding after neonatal dopamine depletion in rats. Moy SS Pharmacol Biochem Behav; 1995 Oct; 52(2):433-41. PubMed ID: 8577812 [TBL] [Abstract][Full Text] [Related]
5. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767 [TBL] [Abstract][Full Text] [Related]
6. [Effects of neurotensin microinjected into ventral tegmental area on spontaneous motor activity in neonatal 6-hydroxydopamine-treated rats]. Ikegami M; Iwasaki T Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Apr; 24(2):83-5. PubMed ID: 15164616 [TBL] [Abstract][Full Text] [Related]
7. Neonatal and adult 6-hydroxydopamine-induced lesions differentially alter tachykinin and enkephalin gene expression. Sivam SP; Breese GR; Krause JE; Napier TC; Mueller RA; Hong JS J Neurochem; 1987 Nov; 49(5):1623-33. PubMed ID: 2889804 [TBL] [Abstract][Full Text] [Related]
8. Hyperactivity and hypoactivity produced by lesions to the mesolimbic dopamine system. Koob GF; Stinus L; Le Moal M Behav Brain Res; 1981 Nov; 3(3):341-59. PubMed ID: 6796098 [TBL] [Abstract][Full Text] [Related]
9. Mesolimbic dopamine and early post-6-OHDA lesion enhanced responses to d-amphetamine. Lynch MR; Carey RJ Pharmacol Biochem Behav; 1989 Feb; 32(2):577-80. PubMed ID: 2498910 [TBL] [Abstract][Full Text] [Related]
10. Elevated serotonin is involved in hyperactivity but not in the paradoxical effect of amphetamine in mice neonatally lesioned with 6-hydroxydopamine. Avale ME; Nemirovsky SI; Raisman-Vozari R; Rubinstein M J Neurosci Res; 2004 Oct; 78(2):289-96. PubMed ID: 15378510 [TBL] [Abstract][Full Text] [Related]
11. Functional changes induced by neonatal cerebral 6-hydroxydopamine treatment: effects of dose levels on behavioral parameters. Luthman J; Bassen M; Fredriksson A; Archer T Behav Brain Res; 1997 Jan; 82(2):213-21. PubMed ID: 9030403 [TBL] [Abstract][Full Text] [Related]
12. Food intake of rats depleted of dopamine as neonates is impaired by inhibition of catecholamine biosynthesis. Potter BM; Bruno JP Neurosci Lett; 1989 Dec; 107(1-3):295-300. PubMed ID: 2515502 [TBL] [Abstract][Full Text] [Related]
13. Thyrotropin-releasing hormone: hyperactivity and mesolimbic dopamine system in rats. Miyamoto M; Narumi S; Nagai Y; Shima T; Nagawa Y Jpn J Pharmacol; 1979 Jun; 29(3):335-47. PubMed ID: 119887 [TBL] [Abstract][Full Text] [Related]
14. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain. Costall B; Marsden CD; Naylor RJ; Pycock CJ Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957 [TBL] [Abstract][Full Text] [Related]
15. Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Wang JY; Wu JN; Cherng TL; Hoffer BJ; Chen HH; Borlongan CV; Wang Y Brain Res; 2001 Jun; 904(1):67-75. PubMed ID: 11516412 [TBL] [Abstract][Full Text] [Related]
16. Neonatal 6-hydroxydopamine lesions of the frontal cortex in rats: persisting effects on locomotor activity, learning and nicotine self-administration. Rezvani AH; Eddins D; Slade S; Hampton DS; Christopher NC; Petro A; Horton K; Johnson M; Levin ED Neuroscience; 2008 Jun; 154(3):885-97. PubMed ID: 18511204 [TBL] [Abstract][Full Text] [Related]
17. Altered activity patterns following neonatal 6-hydroxydopamine lesions to dopaminergic neurons: effect of SKF-38393. Moy SS; Breese GR; Eckerman DA Brain Res; 1994 May; 645(1-2):49-60. PubMed ID: 8062100 [TBL] [Abstract][Full Text] [Related]
18. In vivo electrochemical measurements and electrophysiological studies of rat striatum following neonatal 6-hydroxydopamine treatment. Luthman J; Friedemann M; Bickford P; Olson L; Hoffer BJ; Gerhardt GA Neuroscience; 1993 Feb; 52(3):677-87. PubMed ID: 7680793 [TBL] [Abstract][Full Text] [Related]
19. Effects of B-HT 920 on nigrostriatal and mesolimbic dopamine systems in normosensitive and supersensitive rats. Clarke PB; Wyder KJ; Jakubovic A; Fibiger HC Br J Pharmacol; 1990 Mar; 99(3):509-15. PubMed ID: 2110017 [TBL] [Abstract][Full Text] [Related]
20. Proposed animal model of attention deficit hyperactivity disorder. Kostrzewa RM; Brus R; Kalbfleisch JH; Perry KW; Fuller RW Brain Res Bull; 1994; 34(2):161-7. PubMed ID: 7913871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]